REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Chemi Pharm Group (Lithuania)

Main Activities: Chemical and Allied Products Merchant Wholesalers | Other Chemical and Allied Products Merchant Wholesalers
Full name: UAB Chemi Pharm Group Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Chemi Pharm Group is based in Lithuania, with the head office in Vilnius. The company operates in the Chemical and Allied Products Merchant Wholesalers sector. It was established on March 21, 2000. There are currently 6 (2025) people employed by UAB Chemi Pharm Group. From the latest financial highlights, UAB Chemi Pharm Group reported a net sales revenue increase of 23.62% in 2024. The net profit margin of UAB Chemi Pharm Group decreased by 4.51% in 2024.

Headquarters
Kalvariju g. 125
Vilnius; Vilnius county; Postal Code: LT-08221

Contact Details: Purchase the UAB Chemi Pharm Group report to view the information.

Basic Information
Total Employees:
Purchase the UAB Chemi Pharm Group report to view the information.
Registered Capital:
Purchase the UAB Chemi Pharm Group report to view the information.
Financial Auditors:
Purchase the UAB Chemi Pharm Group report to view the information.
Incorporation Date:
March 21, 2000
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Chemi Pharm Group report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
23.62%
Total Operating Revenue
23.62%
Net Profit/Loss for the Period
-51.78%
Total Equity
-14.81%
Net Profit Margin
-4.51%
Return on Equity (ROE)
-6.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?